A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension Intervention: Combination Product: Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI) Sponsor: Respira Therapeutics, Inc. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials